UBS analyst David Dai downgraded Nanobiotix (NBTX – Research Report) to a Hold today and set a price target of $3.50. The company’s shares closed last Friday at $4.03. Leverage the power of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback